HAI's activities involving WHO

HAI actively lobbies on drug policy at various fora involving the World Health Organization (WHO)

Below is a listing of its latest advocacy work involving WHO:

2000

HAI speaks out on access and industry sponsorship at the 105^th WHO Executive Board meeting in January

CI/HAI Statement on WHO's partnership with industry

CI/HAI Statement on Access to essential medicines

HAI Letter on EB Issues sent to All Members of the WHO Executive Board

Click here to obtain copies of WHO 105^th session Executive Board Documentation